Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy

Heart, Artery and Coronary Diseases

Conduction Abnormalities and Long-Term Mortality Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy

J Am Coll Cardiol.

Cui H, Schaff HV, Nishimura RA, Geske JB, Dearani JA, Lahr BD, Ommen SR

doi: 10.1016/j.jacc.2019.05.053.

Heart, Artery and Coronary Diseases

Women with hypertrophic cardiomyopathy have worse survival

European Heart Journal.

Geske JB, Ong KC, Siontis KC, Hebl VB, Ackerman MJ, Hodge DO, Miller VM, Nishimura RA, Oh JK, Schaff HV, Gersh BJ, Ommen SR

Cardiac Arrest or DeathHeart, Artery and Coronary Diseases

Safety of Outpatient Initiation of Disopyramide for Obstructive Hypertrophic Cardiomyopathy Patients

J Am Heart Assoc.

Adler A, Fourey D, Weissler-Snir A, Hindieh W, Chan RH, Gollob MH, Rakowski H

doi: 10.1161/JAHA.116.005152.

Atrial Fibrillation

Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy

J Am Heart Assoc.

Rozen G, Elbaz-Greener G, Marai I, Andria N, Hosseini SM, Biton Y, Heist EK, Ruskin JN, Gavrilov Y, Carasso S, Ghanim D, Amir O

doi: 10.1161/JAHA.119.015721.

Heart, Artery and Coronary Diseases

Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European Population

JAMA Cardiol.

Lorenzini M, Anastasiou Z, O'Mahony C, Guttman OP, Gimeno JR, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Garcia-Pavia P, Limongelli G, Pavlou M, Elliott PM, Hypertrophic Cardiomyopathy Outcomes investigators.

doi: 10.1001/jamacardio.2019.4534.

Heart, Artery and Coronary Diseases

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet.

Olivotto I, Oreziak A, Barriales-Villa R, Abraham TP, Masri A, Garcia-Pavia P, Saberi S, Lakdawala NK, Wheeler MT, Owens A, Kubanek M, Wojakowski W, Jensen MK, Gimeno-Blanes J, Afshar K, Myers J, Hegde SM, Solomon SD, Sehnert AJ, Zhang D, Li W, Bhattacharya M, Edelberg JM, Waldman CB, Lester SJ, Wang A, Ho CY, Jacoby D, EXPLORER-HCM study investigators

doi: 10.1016/S0140-6736(20)31792-X.

Cardiac Arrest or DeathHeart, Artery and Coronary Diseases

Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical Trial

JAMA.

Saberi S, Wheeler M, Bragg-Gresham J, Hornsby W, Agarwal PP, Attili A, Concannon M, Dries AM, Shmargad Y, Salisbury H, Kumar S, Herrera J, Myers J, Helms AS, Ashley EA, Day SM

doi: 10.1001/jama.2017.2503.

Heart, Artery and Coronary Diseases

Effect of Trimetazidine Dihydrochloride Therapy on Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Clinical Trial

JAMA Cardiol.

Coats CJ, Pavlou M, Watkinson OT, Protonotarios A, Moss L, Hyland R, Rantell K, Pantazis AA, Tome M, McKenna WJ, Frenneaux MP, Omar R, Elliott PM

doi: 10.1001/jamacardio.2018.4847.

Atrial FibrillationHeart, Artery and Coronary DiseasesHeart FailureThrombosis and StrokeTherapy and Intervention

Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy

Circulation.

Rowin EJ, Hausvater A, Link MS, Abt P, Gionfriddo W, Wang W, Rastegar H, Estes NAM 3rd, Maron MS, Maron BJ

doi: 10.1161/

Related content

Conduction Abnormalities and Long-Term Mortality Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy

Women with hypertrophic cardiomyopathy have worse survival

Safety of Outpatient Initiation of Disopyramide for Obstructive Hypertrophic Cardiomyopathy Patients

Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy

Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European Population

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical Trial

Effect of Trimetazidine Dihydrochloride Therapy on Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Clinical Trial

Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy